Á×Ö¬õ£Ë¿°±Ë᣺ҽѧÓëÓªÑøÑ§ÖеÄË«ÖØÓ¦ÓÃ-ÔÆ¶¥¹ú¼Êvip.888" /> ÔÚÕæºËϸ°ûÖУ¬£¬£¬£¬£¬£¬Ö¬ÖÊÔÚÉúÎïĤÉϵÄÂþÑܾßÓÐ²î³Ø³ÆÐÔ¡£¡£¡£¡£¡£¡£Ïêϸ¶øÑÔ£¬£¬£¬£¬£¬£¬ÇÊÌÇÖ¬¡¢ÇÊÁ×Ö¬ºÍÁ×Ö¬õ£µ¨¼îµÈÖ÷ÒªÂþÑÜÔÚϸ°ûĤÍâ²à£¬£¬£¬£¬£¬£¬¶ø°±»ùÁ×Ö¬ÈçÁ×Ö¬õ£ÒÒ´¼°·ºÍÁ×Ö¬õ£Ë¿°±ËᣨPS£©Ö÷ÒªÂþÑÜÔÚϸ°ûÄڲࡣ¡£¡£¡£¡£¡£PSÊÇÒ»ÀàÓɳ¤Á´Ö¬·¾Ëᣬ£¬£¬£¬£¬£¬¸Ê-ÔÆ¶¥¹ú¼Êvip.888" /> Á×Ö¬õ£Ë¿°±Ë᣺ҽѧÓëÓªÑøÑ§ÖеÄË«ÖØÓ¦ÓÃ-ÔÆ¶¥¹ú¼Êvip.888"> ÔÚÕæºËϸ°ûÖУ¬£¬£¬£¬£¬£¬Ö¬ÖÊÔÚÉúÎïĤÉϵÄÂþÑܾßÓÐ²î³Ø³ÆÐÔ¡£¡£¡£¡£¡£¡£Ïêϸ¶øÑÔ£¬£¬£¬£¬£¬£¬ÇÊÌÇÖ¬¡¢ÇÊÁ×Ö¬ºÍÁ×Ö¬õ£µ¨¼îµÈÖ÷ÒªÂþÑÜÔÚϸ°ûĤÍâ²à£¬£¬£¬£¬£¬£¬¶ø°±»ùÁ×Ö¬ÈçÁ×Ö¬õ£ÒÒ´¼°·ºÍÁ×Ö¬õ£Ë¿°±ËᣨPS£©Ö÷ÒªÂþÑÜÔÚϸ°ûÄڲࡣ¡£¡£¡£¡£¡£PSÊÇÒ»ÀàÓɳ¤Á´Ö¬·¾Ëᣬ£¬£¬£¬£¬£¬¸Ê-ÔÆ¶¥¹ú¼Êvip.888"> ÔÆ¶¥¹ú¼Êvip.888">
ÐÂÎŶ¯Ì¬
ÔÚÕæºËϸ°ûÖУ¬£¬£¬£¬£¬£¬Ö¬ÖÊÔÚÉúÎïĤÉϵÄÂþÑܾßÓÐ²î³Ø³ÆÐÔ¡£¡£¡£¡£¡£¡£Ïêϸ¶øÑÔ£¬£¬£¬£¬£¬£¬ÇÊÌÇÖ¬¡¢ÇÊÁ×Ö¬ºÍÁ×Ö¬õ£µ¨¼îµÈÖ÷ÒªÂþÑÜÔÚϸ°ûĤÍâ²à£¬£¬£¬£¬£¬£¬¶ø°±»ùÁ×Ö¬ÈçÁ×Ö¬õ£ÒÒ´¼°·ºÍÁ×Ö¬õ£Ë¿°±ËᣨPS£©Ö÷ÒªÂþÑÜÔÚϸ°ûÄڲࡣ¡£¡£¡£¡£¡£PSÊÇÒ»ÀàÓɳ¤Á´Ö¬·¾Ëᣬ£¬£¬£¬£¬£¬¸ÊÓ͹ǼܺÍÁ×֬ͷ»ù×é³ÉµÄ»¯ºÏÎ£¬£¬£¬£¬£¬½á¹¹Í¨Ê½¼ûÏÂͼ£º

ͼһ Á×Ö¬õ£Ë¿°±ËáµÄ½á¹¹Í¨Ê½
Á×Ö¬õ£Ë¿°±Ëá×÷ÎªÕæºËϸ°ûÖк¬Á¿×î¸ßµÄÒõÀë×ÓÁ×Ö¬£¬£¬£¬£¬£¬£¬Ô¼Õ¼Ï¸°û×ÜÖ¬ÖʵÄ10%£¬£¬£¬£¬£¬£¬¶Ôµ÷ÖÎϸ°ûĤµÄÁ÷¶¯ÐÔºÍͨ͸ÐÔ¾ßÓÐÒªº¦×÷Ó㬣¬£¬£¬£¬£¬²¢ÇÒÄܼ¤»î¶àÖÖøÀàµÄ´úлºÍºÏ³É¡£¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬PS¹ØÓÚ¸ÄÉÆÉñ¾Ï¸°û¹¦Ð§£¬£¬£¬£¬£¬£¬µ÷ÀíÉñ¾ÐźÅת´ïºÍÔö½ø´óÄÔÓ°Ïó¹¦Ð§¾ßÓÐÆð¾¢Ó°Ïì¡£¡£¡£¡£¡£¡£
ÈËÌåÄܹ»×ÔÖ÷ºÏ³ÉPS£¬£¬£¬£¬£¬£¬Í¬Ê±Ò²¿ÉÒÔͨ¹ýʳÎïµÈÍⲿ;¾¶»ñÈ¡¡£¡£¡£¡£¡£¡£ÔÚ´óÄÔÉñ¾Ï¸°ûµÄĤ½á¹¹ÖУ¬£¬£¬£¬£¬£¬PSµÄŨ¶ÈÓÈΪͻ³ö£¬£¬£¬£¬£¬£¬ÆäÔÚĤÉÏµÄ²î³Ø³ÆÂþÑܹØÓÚά³Öϸ°ûÕý³£ÐÄÀí¹¦Ð§ÖÁ¹ØÖ÷Òª¡£¡£¡£¡£¡£¡£
ÔÚ¿µ½¡Ï¸°ûÖУ¬£¬£¬£¬£¬£¬PS¼ÓÈëÄýѪÀú³Ì£¬£¬£¬£¬£¬£¬³É¼¡Ï¸°ûÈÚºÏÒÔ¼°TÁܰÍϸ°û»î»¯µÈ¶àÖÖÐÄÀí¹¦Ð§¡£¡£¡£¡£¡£¡£ËüÊÇϸ°ûµòÍöµÄÆæÒìÌØÕ÷£¬£¬£¬£¬£¬£¬Äܹ»ÎªÏ¸°ûµòÍöÌṩ¿Éʶ±ðºÍ¿ÉÇø·ÖµÄÐźš£¡£¡£¡£¡£¡£ÔÚ¿µ½¡Ï¸°ûÖУ¬£¬£¬£¬£¬£¬PSλÓÚϸ°ûĤÄڲ࣬£¬£¬£¬£¬£¬¶øµ±Ï¸°û×îÏȵòÍöʱ£¬£¬£¬£¬£¬£¬PS»á´Óϸ°ûĤµÄÄÚ²à·×ªµ½Ï¸°ûĤµÄÍâò£¬£¬£¬£¬£¬£¬Ì»Â¶ÓÚ°ûÍâÇéÐÎÖУ¬£¬£¬£¬£¬£¬´Ó¶ø×÷ΪµòÍöϸ°ûµÄÐźţ¬£¬£¬£¬£¬£¬±»¾ÞÊÉϸ°ûÖбí´ïµÄPSÊÜÌåʶ±ð²¢É¨³ý¡£¡£¡£¡£¡£¡£
ÔÚÖ×Áö΢ÇéÐÎÖУ¬£¬£¬£¬£¬£¬PSÔÚÖ×Áöϸ°ûºÍÃâÒßϸ°ûÍâòµÄ̻¶ÓëÃâÒßÒÖÖÆºÍÖ×ÁöÉú³¤µÄÔö½øÓйأ¬£¬£¬£¬£¬£¬Òò´Ë£¬£¬£¬£¬£¬£¬PSÔÚϸ°ûĤÉϵÄλÖùØÓÚϸ°ûµÄ´æ»î¡¢Éú³¤¡¢ÔöÖ³ÒÔ¼°°©Ö¢Ïà¹ØÖ¢×´¾ßÓÐÖØ´óÒâÒå¡£¡£¡£¡£¡£¡£
°ÐÏòPS±»ÒÔΪÊǰ©Ö¢ÖÎÁƵÄÒ»ÖÖÓÐǰ;µÄÕ½ÂÔ£¬£¬£¬£¬£¬£¬½üÄêÀ´£¬£¬£¬£¬£¬£¬¿ÆÑ§¼ÒÃÇÒѾ¿ª·¢³ö¶àÖÖ°ÐÏòPSµÄÒ©Î£¬£¬£¬£¬£¬ÓÃÓÚ°©Ö¢ÖÎÁÆ¡£¡£¡£¡£¡£¡£ÔÚÁÙ´²ÊÔÑéÖУ¬£¬£¬£¬£¬£¬°ÍάÍ×Îôµ¥¿¹×÷Ϊ¼òµ¥Ò©Îï»òÓëÆäËû¹Å°åÖÎÁÆÒªÁìÍŽáÓ¦Ó㬣¬£¬£¬£¬£¬Òѱ»Ö¤ÊµÔÚÖÎÁƷΰ©¡¢¸Îϸ°û°©¡¢ÈéÏÙ°©¡¢ÒÈÏÙ°©ºÍÆäËûʵÌåÁö·½Ãæ¾ßÓÐÁÆÐ§£¬£¬£¬£¬£¬£¬²¢ÇÒ±¬·¢µÄ¸±×÷ÓÃÏà¶Ô½ÏÉÙ¡£¡£¡£¡£¡£¡£±ðµÄ£¬£¬£¬£¬£¬£¬°ÍάÍ×Îôµ¥¿¹ÓëË÷À·ÇÄáÍŽáÖÎÁƸÎϸ°û°©£¬£¬£¬£¬£¬£¬ÒÔ¼°Ó뼪Î÷Ëû±õÍŽáÖÎÁÆÒÈÏÙ°©£¬£¬£¬£¬£¬£¬Ò²Õ¹ÏÖ³öÁËÏÔÖøµÄÖÎÁÆÐ§¹û¡£¡£¡£¡£¡£¡£ÕâЩ·¢Ã÷Ϊ°©Ö¢ÖÎÁÆ¿ª·¢ÁËеĿÉÄÜÐÔ¡£¡£¡£¡£¡£¡£³ý´ËÖ®Í⣬£¬£¬£¬£¬£¬¿¹ÌåżÁªÒ©Î£¬£¬£¬£¬£¬Ö¬ÖÊÌåÔØÌåÒ²ÊÇDZÔÚµÄÓÃÓÚÖÎÁÆÖ×ÁöµÄ°ÐÏòPSÕ½ÂÔ¡£¡£¡£¡£¡£¡£
ÔÚÉñ¾ÉúÎïѧÁìÓò£¬£¬£¬£¬£¬£¬PSÔÚÉñ¾Ï¸°ûĤÖк¬Á¿¸»ºñ£¬£¬£¬£¬£¬£¬¶ÔÉñ¾Ï¸°ûµÄ´æ»î¡¢ÐÞ¸´ºÍ¹¦Ð§Ê©Õ¹ÖÁ¹ØÖ÷Òª¡£¡£¡£¡£¡£¡£PSÔÚÖÐÊàÉñ¾ÏµÍ³ÖеÄÖ÷Òª×÷ÓðüÀ¨Ôö½ø¶à°Í°·µÄÊÍ·Å£¬£¬£¬£¬£¬£¬ÔöÌíÉñ¾µÝÖÊÒÒõ£µ¨¼îµÄÌìÉú£¬£¬£¬£¬£¬£¬ÌáÉýÄÔÆÏÌÑÌÇ´úлЧÂÊ£¬£¬£¬£¬£¬£¬½µµÍÇ⻯¿ÉµÄËÉˮƽ£¬£¬£¬£¬£¬£¬ÒÔ¼°ÔöÇ¿Éñ¾Éú³¤Òò×ӵĻîÐԵȡ£¡£¡£¡£¡£¡£Òò´Ë£¬£¬£¬£¬£¬£¬PSÔÚ¶àÖÖÖÐÊàÉñ¾ÏµÍ³¼²²¡ÖÐÊÎÑÝ×ÅÖ÷Òª½ÇÉ«£¬£¬£¬£¬£¬£¬Õ⺸ÇÁ˰¢¶û´Äº£Ä¬²¡¡¢ÅÁ½ðɲ¡¡¢ÒÖÓôÖ¢¡¢È±ÑªÐÔÖз硢×Ô±ÕÖ¢¡¢×¢ÖØÁ¦È±ÏݶදÕϰ¡¢¾«ÉñÆÆËéÖ¢ÒÔ¼°¼¹ËèËðÉ˵Ȳ¡Ö¢¡£¡£¡£¡£¡£¡£
Ëæ×ÅÄêËêÔöÌí£¬£¬£¬£¬£¬£¬´óÄÔÖе¨¹Ì´¼Ë®Æ½ÉÏÉý¶øÁ×Ö¬õ£Ë¿°±ËᣨPS£©º¬Á¿Ï½µ£¬£¬£¬£¬£¬£¬Õâ»áµ¼Ö´óÄÔϸ°ûÄÚø»îÐÔÏ÷Èõ¡¢Ï¸°ûÔËÊäÄÜÁ¦½µµÍÒÔ¼°Í»´¥ÅþÁ¬ïÔÌ£¬£¬£¬£¬£¬£¬×îÖÕÒýÆðÓ°ÏóÁ¦¼õÍË¡£¡£¡£¡£¡£¡£°¢¶û´Äº£Ä¬²¡£¡£¡£¡£¡£¡£¨AD£©ÊÇÒ»ÖÖÂýÐÔÉñ¾ÍËÐÐÐÔ¼²²¡£¬£¬£¬£¬£¬£¬ÊÇÍíÄê³Õ´ô֢ϵÁÐ×î³£¼ûµÄÒ»ÖÖ¼²²¡¡£¡£¡£¡£¡£¡£Ïà¹ØÁÙ´²Ñо¿Åú×¢£¬£¬£¬£¬£¬£¬ÖðÈÕÈý´Î£¬£¬£¬£¬£¬£¬Ã¿´ÎÔö²¹100ºÁ¿ËPS£¬£¬£¬£¬£¬£¬Ò»Á¬·þÓÃ12ÖÜ£¬£¬£¬£¬£¬£¬ÄÜÏÔÖø¸ÄÉÆAD»¼ÕßµÄÈÏÖª¹¦Ð§ºÍÓ°ÏóÁ¦¡£¡£¡£¡£¡£¡£Í¬Ê±£¬£¬£¬£¬£¬£¬½«300ºÁ¿ËPSÓë240ºÁ¿ËPAÍŽáʹÓ㬣¬£¬£¬£¬£¬Ò²ÏÔʾ³ö¶Ô¸ÄÉÆ»¼ÕßÇéÐ÷ºÍÒ»Ñùƽ³£ÉúÑÄÖÊÁ¿µÄÆð¾¢Ð§¹û¡£¡£¡£¡£¡£¡£
×¢ÖØÁ¦È±ÏݶදÕϰ£¨ADHD£©¼´¶à¶¯Ö¢ÊÇÒ»ÖÖÉñ¾·¢ÓýÕϰ£¬£¬£¬£¬£¬£¬ÌØÕ÷ÌåÏÖÎª×¢ÖØÁ¦²»¼¯ÖУ¬£¬£¬£¬£¬£¬Ò×¼¤¶¯£¬£¬£¬£¬£¬£¬Ì«¹ý»îÔ¾µÈ¡£¡£¡£¡£¡£¡£ÏÖÔÚÓÃÓÚÖÎÁÆADHDµÄÒ©Î£¬£¬£¬£¬£¬²¢²»ÊÇËùÓжùͯ¶¼ÄÜÓÐÏìÓ¦»òÄÍÊÜ£¬£¬£¬£¬£¬£¬HirayamaÍŶÓÁÙ´²Ñо¿·¢Ã÷£¬£¬£¬£¬£¬£¬Ò»Á¬2¸öÔÂÌìÌìÔö²¹200 ºÁ¿Ë PS£¬£¬£¬£¬£¬£¬¿ÉÒÔÏÔÖø¸ÄÉÆADHD¶ùͯµÄÕûÌåÖ¢×´ºÍ¶ÌÆÚÌý¾õÓ°Ï󡣡£¡£¡£¡£¡£
Á×Ö¬õ£Ë¿°±ËáÊÇÒ»ÖÖÔÚÈËÌåÄÚ×ÔÈ»±£´æµÄÁ×Ö¬ÓªÑøËØ£¬£¬£¬£¬£¬£¬ÓÈÆäÔÚ´óÄÔ¡¢·Î¡¢ÐÄÔà¡¢¸ÎÔàºÍ¹Ç÷À¼¡µÈ´úл»îÔ¾µÄÆ÷¹ÙÖк¬Á¿¸»ºñ¡£¡£¡£¡£¡£¡£PSÄÜÓë¶àÖÖÂѰ×ÖÊÍŽᣬ£¬£¬£¬£¬£¬¼ÓÈëµ÷¿Ø¶àÖÖÉúÎïÀú³Ì£¬£¬£¬£¬£¬£¬°üÀ¨Ã¸µÄ¼¤»î¡¢Ï¸°ûµÄµòÍöÒÔ¼°Éñ¾ÐźŵÄת´ïµÈ¡£¡£¡£¡£¡£¡£Ôö²¹PS²»µ«¹ØÓÚÖÎÁÆÖÐÊàÉñ¾ÏµÍ³¼²²¡Èç°¢¶û´Äº£Ä¬²¡ÓÐÆð¾¢×÷Ó㬣¬£¬£¬£¬£¬»¹ÔÚ°©Ö¢ÖÎÁÆÖÐÏÔʾ³öDZÁ¦£¬£¬£¬£¬£¬£¬»¹ÆÕ±éÓ¦ÓÃÓÚÓªÑøÑ§ÁìÓò£¬£¬£¬£¬£¬£¬ÀýÈç¸ÄÉÆÇéÐ÷ºÍ¿µ½¡×´Ì¬£¬£¬£¬£¬£¬£¬Ìá¸ßÈÏÖª¹¦Ð§ºÍÔ˶¯ÌåÏÖ£¬£¬£¬£¬£¬£¬»º½â¼¡ÈâËáÍ´£¬£¬£¬£¬£¬£¬¸ÄÉÆË¯Ãߵȡ£¡£¡£¡£¡£¡£
ThorntonÍŶӵÄÑо¿Ð§¹ûÅú×¢£¬£¬£¬£¬£¬£¬Ôö²¹PSÄÜÓÐÓøÄÉÆÄêÇ῵½¡´óѧÉúµÄÈÏÖª¹¦Ð§£¬£¬£¬£¬£¬£¬ÏêϸÌåÏÖΪÅÌËãËÙÂÊÌá¸ß20%£¬£¬£¬£¬£¬£¬¹ýʧ×ÜÁ¿ïÔÌ39%£¬£¬£¬£¬£¬£¬×¼È·ÅÌËã×ÜÁ¿Ìá¸ß13%¡£¡£¡£¡£¡£¡£
±ðµÄ£¬£¬£¬£¬£¬£¬PS»¹Äܹ»ÔöÇ¿¸öÌåµÄ¿¹Ñ¹ÄÜÁ¦£¬£¬£¬£¬£¬£¬²¢¼õ»ºÌ«¹ýÔ˶¯´øÀ´µÄÐÄÀíѹÁ¦¡£¡£¡£¡£¡£¡£Â½æ¯æ¯ºÍ°²ÑàµÈÑо¿Õߵķ¢Ã÷ÏÔʾ£¬£¬£¬£¬£¬£¬¸ßˮƽÉä»÷ÔË·¢¶¯ÔÚ½ÇÖðǰÔö²¹800mg/dµÄPS£¬£¬£¬£¬£¬£¬Äܹ»Í¨¹ý½µµÍƤÖÊ´¼Ë®Æ½¡¢¸ÄÉÆÐľ³ºÍ˯ÃßÖÊÁ¿£¬£¬£¬£¬£¬£¬´Ó¶øÌáÉýÐÄÀíÓ¦¼¤Ë³Ó¦ÄÜÁ¦¡£¡£¡£¡£¡£¡£
×ÛÉÏËùÊö£¬£¬£¬£¬£¬£¬PSÔÚҽѧºÍÓªÑøÑ§ÁìÓòÓÐ×ÅÆÕ±éµÄÓ¦Ó㬣¬£¬£¬£¬£¬È»¶ø£¬£¬£¬£¬£¬£¬´Ó´ó¶¹»ò¶¯ÎïÔàÆ÷ÖкÜÄÑ»ñµÃ¼òµ¥ÇҸߴ¿¶ÈµÄPS£¬£¬£¬£¬£¬£¬¼òµ¥»¯Ñ§½á¹¹µÄ¸ß´¿¶ÈPSͨ³£ÐèÒª»¯Ñ§ºÏ³É·¨Éú²ú»ñµÃ¡£¡£¡£¡£¡£¡£ÎÒÃǹ«Ë¾Äܹ»Ïò¿ÆÑÐÊÂÇéÕßÌṩÖÖÖָߴ¿¶ÈµÄÁ×Ö¬õ£Ë¿°±Ëᣬ£¬£¬£¬£¬£¬»¶ÓÓÐÐèÇóµÄÅóÙÀ´µç´¹Ñ¯£¡
±íÒ» ÔÆ¶¥¹ú¼Êvip.888ÉúÎï¿ÉÒÔÌṩµÄÏà¹Ø²úÆ·

²Î¿¼ÎÄÏ×£º
[1] Wang, J.; Yu, C.X.; Qi, J.X.; et al. The role of phosphatidylserine on the membrane in immunity and blood coagulation[J]. Biomark Res. 2022, 10, 4.
[2] Kay, J.G.; Fairn, G.D.; Distribution, dynamics and functional roles of phosphatidylserine within the cell[J]. Cell Commun Signal. 2019, 17, 126.
[3] Shlomovitz, I.; Speir, M.; Gerlic, M. Flipping the dogma-phosphatidylserine in non-apoptotic cell death[J]. Cell Commun Signal. 2019, 17, 139.
[4] Chang, W.G.; Fa, H.G.; Xiao, D.D.; Wang, J.X. Targeting phosphatidylserine for Cancer therapy: prospects and challenges[J]. Theranostics. 2020, 10, 9214-9229.
[5] ËÎÊçÁÁ, ¼ª°®¹ú. Á×Ö¬õ£Ë¿°±ËáµÄÖÐÊàÉñ¾×÷ÓÃ[J]. ÖйúÉú»¯Ò©ÎïÔÓÖ¾. 2006, 27, 117-119.
[6] Ma, X.H.; Li, X.J.; Miao, Z.G.; et, al. Phosphatidylserine, inflammation, and central nervous system diseases[J]. Front. Aging Neurosci. 2022, 14, 975176.
[7] Hirayama, S.; Terasawa, K.; J?ger, R.; et al. The effect of phosphatidylserine administration on memory and symptoms of attention- deficit hyperactivity disorder: a randomised, double-blind, placebo- controlled clinical trial[J]. J. Hum. Nutr. Diet. 2013, 27, 284-291.
[8] Starks, M.A.; Starks, S.L.; J?ger, R.; et al. The effects of phosphatidylserine on endocrine response to moderate intensity exercise[J]. J Int Soc Sports Nutr. 2008, 5, 11.
[9] Parker, A.G.; Gordon, J.; Kreider, R.D.; et al. The effects of IQPLUS Focus on cognitive function, mood and endocrine response before and following acute exercise[J]. J Int Soc Sports Nutr. 2011, 8, 16.
[10] J?ger, R.; Purpura, M.; Herwegen, H.; et al. The effect of phosphatidylserine on golf performance[J]. J Int Soc Sports Nutr. 2007, 4, 23.
[11] ½½¿½¿, °²Ñà, Ðíèª, ³ÂÓÀÇ¿. Á×Ö¬õ£Ë¿°±Ëá¶ÔÉä»÷ÔË·¢¶¯ÐÄÀíÓ¦¼¤Ë³Ó¦ÄÜÁ¦¼°ÄÔÄÚÉñ¾µÝÖʼ¤»îˮƽµÄÓ°Ïì[J]. ÓªÑøÑ§±¨. 2019, 41, 439-443.
